NKARTA INC's ticker is NKTX and the CUSIP is 65487U108. A total of 85 filers reported holding NKARTA INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,001 | +442.1% | 1,827 | +778.4% | 0.00% | – |
| Q1 2023 | $738 | -93.8% | 208 | -89.5% | 0.00% | -100.0% |
| Q4 2022 | $11,896 | -54.5% | 1,986 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $26,136 | +6.8% | 1,986 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $24,468 | -77.6% | 1,986 | -49.5% | 0.00% | -50.0% |
| Q3 2021 | $109,377 | -45.2% | 3,933 | -37.6% | 0.00% | -33.3% |
| Q2 2021 | $199,742 | +4.5% | 6,303 | +8.4% | 0.00% | 0.0% |
| Q1 2021 | $191,215 | -37.4% | 5,812 | +16.9% | 0.00% | -40.0% |
| Q4 2020 | $305,690 | +104.5% | 4,973 | 0.0% | 0.01% | +66.7% |
| Q3 2020 | $149,488 | – | 4,973 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 2,034,703 | $31,233,000 | 6.06% |
| Novo Holdings A/S | 2,793,864 | $42,886,000 | 2.03% |
| RA Capital Management | 5,605,129 | $86,039,000 | 1.52% |
| Deep Track Capital, LP | 1,264,426 | $19,409,000 | 1.37% |
| NEA Management Company, LLC | 2,904,974 | $44,591,000 | 0.90% |
| Vivo Capital, LLC | 512,225 | $7,863,000 | 0.47% |
| Pinz Capital Management, LP | 40,000 | $614,000 | 0.24% |
| Rock Springs Capital Management LP | 507,248 | $7,786,000 | 0.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 40,200 | $617,000 | 0.14% |
| EMC Capital Management | 12,548 | $193,000 | 0.10% |